Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer

Raf Kinase inhibitory protein (RKIP) is a well-established metastasis suppressor that is frequently downregulated in aggressive cancers. The impact of RKIP and its phosphorylated form on disease-free survival (DFS) and other clinicopathological parameters in breast cancer is yet to be discovered. To...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Al-Mulla, Fahd, Bitar, Milad S, Thiery, Jean Paul, Zea, Tan Tuan, Chatterjee, Devasis, Bennett, Lindsay, Park, Sungdae, Edwards, Joanne, Yeung, Kam C
Natura: Artigo
Lingua:Inglês
Pubblicazione: e-Century Publishing Corporation 2013
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3816965/
https://ncbi.nlm.nih.gov/pubmed/24224123
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi